# Heparin

## HEPAC inj 25KIU/5mL

| 藥物代碼 | IHEPA |
| :--- | :--- |
| 適應症 | Unstable angina; Venous thromboembolism; Peripheral arterial embolism,  Prevention of re-occlusion of the coronary arteries following thrombolytic therapy ,  Venous thromboembolism ,Prophylaxis of post-op venous thromboembolism, Prevention of mural thrombosis |
| 副作用 | Slight fever, headache, chills, nausea, vomiting, constipation, epistaxis, bruising, slight haematuria, skin necrosis \(SC inj\), osteoporosis, alopecia. Hypersensitivity reactions include urticaria, conjunctivitis, rhinitis, asthma, angioedema and anaphylactic shock. Priapism.Potentially Fatal: Heparin-induced thrombocytopenia with or without thrombosis; bleeding Dermatologic: Erythema, Injection site ulcer, After deep subcutaneous injectionHematologic: Hematoma, Heparin-induced thrombocytopenia \(up to 30% \)Neurologic: Pain \(Mild\)Other: Irritation symptom, Local |
| 禁忌 | Patients predisposed to active bleeding including thrombocytopenia, peptic ulcer disease, cerebrovascular disorders, haemorrhagic blood disorders, bacterial endocarditis, severe hypertension, oesophageal varices. Recent surgery at sites where haemorrhage would be an especial risk. Severe renal and hepatic impairment. Cerebral or subarachnoid haemorrhage, abdominal or thoracic bleeding into closed space, severe traumatic bleed, hepatic, renal, splenic or arterial injury, severe haemostatic defect, arterial thrombosis with heparin-associated thrombocytopenia. IM admin. |
| 藥物保存方式 | N/A |
| 用法用量 | IV Unstable angina; Venous thromboembolism; Peripheral arterial embolism Loading dose: 5,000 u, then 1,000-2,000 u/hr. Prevention of re-occlusion of the coronary arteries following thrombolytic therapy in MI 5,000 u, then 1,000 u/hr w/ alteplase. SC Venous thromboembolism 15,000 u 12 hrly. Prophylaxis of post-op venous thromboembolism 5,000 u 2 hr before surgery, then 8-12 hrly for 7 days or until patient is ambulant. Prevention of mural thrombosis 12,500 u 12 hrly for at least 10 days |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IA, IRR, IV, IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【H/S】 可選  【N/S】 可選 仿單建議 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 輸注速率 10~20 u/mL/min |
| 注意事項 | 1.未稀釋亦可使用 2.廠商建議使用稀釋亦為N/S |

## Hepac inj 1KIU/0.2mL

| 藥物代碼 | IHEPA1 |
| :--- | :--- |
| 適應症 | NA |
| 副作用 | NA |
| 禁忌 | NA |
| 藥物保存方式 | N/A |
| 用法用量 | N/A |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IRR, IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Hepac Lock Flush 1000 Unit/10mL

| 藥物代碼 | IHLF |
| :--- | :--- |
| 適應症 | Solution is intended for maintenance of patency of intravenous injection devices only. \(central line use\) |
| 副作用 | Hemorrhage, allergic reactions |
| 禁忌 | Hypersensitivity to the drug, Bleeding disorders, Severe thrombocytopenia, Patients who can't undergo regular blood coagulation tests |
| 藥物保存方式 | 20-25℃ |
| 用法用量 | Adult dosing: Port-A flush only. Hepac Lock Flush Solution is intended for maintenance of patency of intravenous injection devices only and is not to be used for anticoagulant therapy. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Compatible 哺乳時可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IRR, IRRI |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 不可用於肌肉注射。 |

